期刊
CELL RESEARCH
卷 21, 期 1, 页码 22-39出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/cr.2010.166
关键词
deubiquitinases; NF-kappa B; IKK; A20; CYLD
类别
资金
- NIH [PO1CA128115, RO1CA135362, RO1GM083143]
- NATIONAL CANCER INSTITUTE [P01CA128115, R01CA135362] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083143] Funding Source: NIH RePORTER
Nuclear factor-kappa B (NF-kappa B) is a critical regulator of multiple biological functions including innate and adaptive immunity and cell survival. Activation of NF-kappa B is tightly regulated to preclude chronic signaling that may lead to persistent inflammation and cancer. Ubiquitination of key signaling molecules by E3 ubiquitin ligases has emerged as an important regulatory mechanism for NF-kappa B signaling. Deubiquitinases (DUBs) counteract E3 ligases and therefore play a prominent role in the downregulation of NF-kappa B signaling and homeostasis. Understanding the mechanisms of NF-kappa B downregulation by specific DUBs such as A20 and CYLD may provide therapeutic opportunities for the treatment of chronic inflammatory diseases and cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据